# Occipital Blocks for Acute Migraine

> **NCT03526874** · PHASE3 · COMPLETED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 63 (actual)

## Conditions studied

- Chronic Migraine, Headache
- Episodic Migraine

## Interventions

- **DRUG:** Lidocaine 4% Topical Application Cream [LMX 4]
- **DRUG:** Lidocaine Hydrochloride 2 mg/mL Injectable Solution
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT03526874
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-03
- **Primary completion:** 2023-03-10
- **Final completion:** 2023-03-10
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2025-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03526874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03526874, "Occipital Blocks for Acute Migraine". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03526874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*